CTS Corp (CTS) stock
Close on Nov 13, 2026Market cap $1.72BP/E 23.8Yield 0.27%
Earnings
CTS's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of CTS's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 9, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 27, 2026before the open | $149.60M | +4.6% | $0.61 | $0.77 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 28, 2026before the open | $144.80M | +7.3% | $0.66 | $0.74 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026before the open | $139.00M | +10.3% | $0.59 | $0.62 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 10, 2026before the open | $137.00M | +7.9% | $0.67 | $0.62 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 28, 2025before the open | $143.00M | +8.3% | $0.46 | $0.60 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 24, 2025before the open | $135.00M | +3.8% | $0.62 | $0.57 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 30, 2025before the open | $126.00M | +0.2% | $0.44 | $0.44 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 4, 2025before the open | $127.00M | +1.6% | $0.45 | $0.53 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 29, 2024before the open | $132.00M | -2.2% | $0.61 | $0.63 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 30, 2024before the open | $130.00M | -10.5% | $0.48 | $0.54 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 1, 2024before the open | $125.70M | -13.9% | $0.36 | $0.47 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 6, 2024before the open | $125.00M | -12.2% | $0.49 | $0.47 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 26, 2023before the open | $135.00M | -11.1% | $0.44 | $0.54 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 25, 2023before the open | $145.20M | +0.1% | $0.41 | $0.59 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 27, 2023before the open | $146.00M | -1.2% | $0.58 | $0.61 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 7, 2023before the open | $142.30M | +7.4% | $0.47 | $0.56 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 26, 2022before the open | $151.90M | +24.1% | $0.37 | $0.62 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 26, 2022before the open | $145.00M | – | $0.39 | $0.62 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 28, 2022before the open | $147.70M | – | $0.63 | $0.67 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 8, 2022before the open | $132.50M | – | $0.28 | $0.49 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 27, 2021before the open | $122.40M | – | -$1.97 | $0.46 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 27, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 29, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 9, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
CTS's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| salesGAAP | FY2026 | $580.00M – $590.00M | $565.00M – $585.00M | Raised | Oct 27, 2026 |
| sales | FY2026 | $560.00M – $580.00M | $550.00M – $580.00M | Raised | Apr 29, 2026 |
| adjusted diluted EPSnon-GAAP | FY2026 | $2.78 – $2.88 | $2.55 – $2.70 | Raised | Oct 27, 2026 |
| adjusted diluted EPSnon-GAAP | FY2026 | $2.35 – $2.45 | $2.30 – $2.45 | Raised | Apr 29, 2026 |
Guidance vs results
The last range CTS gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | adjusted diluted EPS | $2.20 – $2.25 | $2.23Σ4Q | Within range |
| FY2025 | Revenue | $535.00M – $545.00M | $541.00MΣ4Q | Within range |
Guidance history
Every forecast CTS put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 27, 2026 | adjusted diluted EPS | FY2026 | $2.78 – $2.88 | Raised |
| Oct 27, 2026 | sales | FY2026 | $580.00M – $590.00M | Raised |
| Jul 28, 2026 | adjusted diluted EPS | FY2026 | $2.55 – $2.70 | New |
| Jul 28, 2026 | sales | FY2026 | $565.00M – $585.00M | New |
| Apr 29, 2026 | adjusted diluted EPS | FY2026 | $2.35 – $2.45 | Raised |
| Apr 29, 2026 | sales | FY2026 | $560.00M – $580.00M | Raised |
| Feb 10, 2026 | adjusted diluted EPS | FY2026 | $2.30 – $2.45 | New |
| Feb 10, 2026 | full-year 2026 sales | FY2026 | $550.00M – $580.00M | New |
| Oct 28, 2025 | adjusted diluted EPS | FY2025 | $2.20 – $2.25 | Lowered |
| Oct 28, 2025 | sales | FY2025 | $535.00M – $545.00M | Narrowed |
| Jul 24, 2025 | adjusted diluted EPS | FY2025 | $2.20 – $2.35 | New |
| Jul 24, 2025 | sales | FY2025 | $520.00M – $550.00M | New |
| Apr 30, 2025 | adjusted diluted EPS | FY2025 | $2.20 – $2.35 | Reaffirmed |
| Apr 30, 2025 | sales | FY2025 | $520.00M – $550.00M | Reaffirmed |
| Feb 4, 2025 | adjusted diluted EPS | FY2025 | $2.20 – $2.35 | New |
| Feb 4, 2025 | sales | FY2025 | $520.00M – $550.00M | New |
| Oct 29, 2024 | adjusted diluted EPS | FY2024 | $2.05 – $2.25 | Reaffirmed |
| Oct 29, 2024 | sales | FY2024 | $515.00M – $525.00M | Lowered |
| Jul 30, 2024 | adjusted diluted EPS | FY2024 | $2.05 – $2.25 | Lowered |
| Jul 30, 2024 | sales | FY2024 | $525.00M – $540.00M | Lowered |
| May 1, 2024 | adjusted diluted EPS | FY2024 | $2.10 – $2.35 | Reaffirmed |
| May 1, 2024 | sales | FY2024 | $530.00M – $570.00M | Reaffirmed |
| Feb 6, 2024 | adjusted diluted EPS | FY2024 | $2.10 – $2.35 | New |
| Feb 6, 2024 | sales | FY2024 | $530.00M – $570.00M | New |
| Oct 26, 2023 | adjusted diluted EPS | FY2023 | $2.15 – $2.25 | Lowered |
| Oct 26, 2023 | sales | FY2023 | $545.00M – $555.00M | Lowered |
| Jul 25, 2023 | adjusted diluted EPS | FY2023 | $2.20 – $2.40 | Lowered |
| Jul 25, 2023 | sales | FY2023 | $565.00M – $585.00M | Lowered |
| Apr 27, 2023 | adjusted diluted EPS | FY2023 | $2.40 – $2.70 | Reaffirmed |
| Apr 27, 2023 | sales | FY2023 | $580.00M – $640.00M | New |
| Feb 7, 2023 | adjusted diluted EPS | FY2023 | $2.40 – $2.70 | New |
| Feb 7, 2023 | sales | FY2023 | $580.00M – $640.00M | New |
| Oct 26, 2022 | adjusted diluted EPS | FY2022 | $2.40 – $2.55 | Reaffirmed |
| Oct 26, 2022 | sales | FY2022 | $585.00M – $595.00M | Narrowed |
| Jul 26, 2022 | adjusted diluted EPS | FY2022 | $2.40 – $2.55 | Raised |
| Jul 26, 2022 | sales | FY2022 | $570.00M – $600.00M | Raised |
| Apr 28, 2022 | adjusted diluted EPS | FY2022 | $2.20 – $2.45 | Raised |
| Apr 28, 2022 | sales | FY2022 | $550.00M – $580.00M | New |
| Feb 8, 2022 | adjusted diluted EPS | FY2022 | $2.00 – $2.25 | New |
| Feb 8, 2022 | sales | FY2022 | $525.00M – $550.00M | New |
| Oct 27, 2021 | adjusted diluted EPS | FY2021 | $1.85 – $1.95 | New |
| Oct 27, 2021 | sales | FY2021 | $495.00M – $505.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases CTS filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Update
- Results
See a number that looks wrong?